CIK 0001710072
- Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821725586
- Phone
- +1 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Nofi Michael Chief Financial Officer | Option exercise | +10,937 | 10,937 | ||
| 2026-11-10 | Nofi Michael Chief Financial Officer | Sale | −4,442 | $45.43 | $202K | 6,495 |
| 2026-11-10 | Nofi Michael Chief Financial Officer | Option exercise · Restricted Stock Units | −10,937 | 32,813 | ||
| 2026-08-12 | Nofi Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +48,750 | 48,750 | ||
| 2026-08-12 | Nofi Michael Chief Financial Officer | Grant or award · Restricted Stock Units | +24,375 | 24,375 | ||
| 2026-08-12 | Nofi Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +48,750 | 48,750 | ||
| 2025-11-10 | Nofi Michael Chief Financial Officer | Grant or award · Restricted Stock Units | +43,750 | 43,750 | ||
| 2025-11-10 | Nofi Michael Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +262,500 | 262,500 |
Page 1 of 1 · 8 trades